Pharmacological regulation of gene expression
- PMID: 21708254
- PMCID: PMC3177019
- DOI: 10.1016/j.phrs.2011.05.019
Pharmacological regulation of gene expression
Abstract
Pharmacological regulation of gene expression was one of the top professional interests of Dr. Costa. He promoted the idea that drugs can improve the endogenous mechanisms of synaptic plasticity by modulating gene expression. In this article I reflect upon Dr. Costa's leadership in projects undertaken at FGIN that were aimed at elucidating how neurotransmitter receptor activation could affect brain function by modulating genes and their products. I will be presenting examples of how pharmacological tools can change gene expression. These include the ability of drugs of abuse to alter the synthesis of opioid peptides or an endogenous ligand for GABAA receptor. I will conclude with a brief summary of intriguing discoveries about the regulation of nerve growth factor (NGF) and its receptors by beta-receptor agonists, adrenal steroids and cytokines.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
The FGIN period: electrophysiological studies.Pharmacol Res. 2011 Oct;64(4):316-8. doi: 10.1016/j.phrs.2011.05.020. Epub 2011 Jun 16. Pharmacol Res. 2011. PMID: 21704166 Review.
-
Synergistic effect of dexamethasone and beta-adrenergic receptor agonists on the nerve growth factor gene transcription.Brain Res Mol Brain Res. 2004 May 19;124(2):97-104. doi: 10.1016/j.molbrainres.2004.01.011. Brain Res Mol Brain Res. 2004. PMID: 15135217
-
The golden years: a tribute to Erminio Costa.Pharmacol Res. 2011 Oct;64(4):350-8. doi: 10.1016/j.phrs.2011.05.013. Epub 2011 Jun 16. Pharmacol Res. 2011. PMID: 21708256 Review.
-
CAAT/enhancer-binding protein delta and cAMP-response element-binding protein mediate inducible expression of the nerve growth factor gene in the central nervous system.J Biol Chem. 2006 Jun 30;281(26):17681-8. doi: 10.1074/jbc.M600207200. Epub 2006 Apr 21. J Biol Chem. 2006. PMID: 16632469
-
Pharmacological modulation of nerve growth factor synthesis: a mechanistic comparison of vitamin D receptor and beta(2)-adrenoceptor agonists.Brain Res Mol Brain Res. 2000 Dec 28;85(1-2):179-88. doi: 10.1016/s0169-328x(00)00254-0. Brain Res Mol Brain Res. 2000. PMID: 11146120
References
-
- Costa E, Mocchetti I, Supattapone S, Snyder SH. Opioid peptide biosynthesis: Enzymatic selectivity and regulatory mechanisms. FASEB J. 1987;1:16–21. - PubMed
-
- Mocchetti I, Naranjo JR, Costa E. Regulation of striatal enkephalin turnover in rats receiving antagonists of specific dopamine receptor subtypes. J Pharmacol Exp Ther. 1987;241:1120–1124. - PubMed
-
- Mocchetti I, Ritter A, Costa E. Down-regulation of proopiomelanocortin synthesis and beta-endorphin utilization in hypothalamus of morphine-tolerant rats. J Mol Neurosci. 1989;1:33–38. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources